DE60332239D1 - Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren - Google Patents

Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren

Info

Publication number
DE60332239D1
DE60332239D1 DE60332239T DE60332239T DE60332239D1 DE 60332239 D1 DE60332239 D1 DE 60332239D1 DE 60332239 T DE60332239 T DE 60332239T DE 60332239 T DE60332239 T DE 60332239T DE 60332239 D1 DE60332239 D1 DE 60332239D1
Authority
DE
Germany
Prior art keywords
chemokins
modulate
peptides
chemokine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332239T
Other languages
English (en)
Inventor
Amnon Peled
Orly Eizenberg
Dalit Vaizel-Ohayon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biokine Therapeutics Ltd
Original Assignee
Biokine Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biokine Therapeutics Ltd filed Critical Biokine Therapeutics Ltd
Application granted granted Critical
Publication of DE60332239D1 publication Critical patent/DE60332239D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G11/00—Chutes
    • B65G11/02—Chutes of straight form
    • B65G11/023—Chutes of straight form for articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G11/00—Chutes
    • B65G11/16—Interior surfaces; Linings
    • B65G11/163—Interior surfaces; Linings for articles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DE60332239T 2002-02-28 2003-02-27 Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren Expired - Lifetime DE60332239D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35999502P 2002-02-28 2002-02-28
PCT/IL2003/000155 WO2003072599A2 (en) 2002-02-28 2003-02-27 Novel chemokine binding peptides capable of modulating the biological activity of chemokines

Publications (1)

Publication Number Publication Date
DE60332239D1 true DE60332239D1 (de) 2010-06-02

Family

ID=27766173

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332239T Expired - Lifetime DE60332239D1 (de) 2002-02-28 2003-02-27 Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren

Country Status (6)

Country Link
US (5) US20030221931A1 (de)
EP (2) EP2287175A3 (de)
AT (1) ATE465171T1 (de)
AU (1) AU2003209636A1 (de)
DE (1) DE60332239D1 (de)
WO (1) WO2003072599A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030221931A1 (en) 2002-02-28 2003-12-04 Steve Marsh Sliding device
US7473682B2 (en) * 2003-10-29 2009-01-06 Ramot At Tel Aviv University Ltd. Angiogenic peptides and uses thereof
EP1692506A4 (de) * 2003-11-17 2008-01-09 Janssen Pharmaceutica Nv Modellierung einer systemischen entzündlichen reaktion auf eine infektion
JP2008509062A (ja) * 2004-08-05 2008-03-27 エル−スリー コミュニケーションズ セキュリティー アンド ディテクション システムズ インコーポレイテッド 処理量を増大させた検査ステーション
US7871978B2 (en) * 2004-11-04 2011-01-18 University Of Virginia Patent Foundation Bone tropic peptides
DE102006006208B4 (de) * 2006-02-09 2010-11-11 Smiths Heimann Gmbh Kontrollstation zur Überprüfung von Handgepäck und anderen von Personen mitgeführten Gegenständen
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US20090324596A1 (en) 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US9516460B2 (en) 2008-03-28 2016-12-06 Securitypoint Holdings Llc Systems and methods for security checkpoint condition information and sharing
US9116513B2 (en) 2008-03-28 2015-08-25 Securitypoint Holdings, Inc. Methods and systems for efficient security screening
US8394758B2 (en) * 2008-10-29 2013-03-12 Academia Sinica Tumor-targeting peptides and uses thereof
MX2011013459A (es) 2009-06-14 2012-05-08 Biokine Therapeutics Ltd Terapia de peptido para incrementar los niveles de plaquetas.
CA2765188A1 (en) * 2009-06-15 2010-12-23 Biokine Therapeutics Ltd. Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
EP2385057A1 (de) * 2010-05-05 2011-11-09 Centre National de la Recherche Scientifique Peptidderivate zur Biofunktionalisierung von Siliciumsubstraten und deren Anwendungen
CN102174080B (zh) * 2010-09-19 2014-07-09 复旦大学 具有脑靶向递药特性的多肽及其制备方法
EP2632939A4 (de) 2010-10-25 2014-05-14 Academia Sinica Taiwan Auf krebs abgezielte peptide und ihre verwendung in der krebsbehandlung und -diagnose
MX365242B (es) 2011-05-16 2019-05-28 Genzyme Corp El uso del antagonista cxcr4: 1,1´-[1,4-fenileno-bis-(metileno)-bi s-1, 4, 8, 11-tetraazaciclotetradecano (plerixaflor) para el tratamiento del síndrome de whim.
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
FR3022142B1 (fr) 2014-06-16 2019-07-12 Universite Paul Sabatier - Toulouse Iii Inhibition de la chimiokine ccl7 ou de son recepteur ccr3 pour le traitement et le diagnostic du cancer de la prostate
EP3322431A2 (de) 2015-07-16 2018-05-23 Biokine Therapeutics Ltd. Zusammensetzungen und verfahren zur behandlung von krebs
WO2017103932A1 (en) 2015-12-17 2017-06-22 Biokine Therapeutics Ltd. Small molecules for inhibiting chemokine activity, a kinase activity and/or cancer cells growth
EP3390378B1 (de) 2015-12-17 2022-03-30 AlonBio Ltd. Kleine moleküle gegen krebs
AU2017222495B2 (en) 2016-02-23 2019-08-08 Biolinerx Ltd. Methods of treating acute myeloid leukemia
EP3864025A4 (de) 2018-10-12 2022-07-20 Theradaptive, Inc. Polypeptide mit einer beta-tricalciumphosphatbindenden sequenz und deren verwendungen
CN114096524A (zh) 2019-05-15 2022-02-25 阿龙拜欧有限公司 用于治疗癌症、抑制趋化因子活性和/或诱导细胞死亡的小分子
US20230203115A1 (en) * 2020-03-06 2023-06-29 Theradaptive, Inc. Therapeutic compositions comprising graft materials and beta-tcp binding peptides and uses thereof
GB202209520D0 (en) 2022-06-29 2022-08-10 Univ Oxford Innovation Ltd Peptides

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US192164A (en) * 1877-06-19 Improvement in bathing apparatus
US318320A (en) * 1885-05-19 Ajstsel steickland
US39211A (en) * 1863-07-14 Improved skid for discharging and loading vessels
US243451A (en) * 1881-06-28 Automatic cash-carrier
US250025A (en) * 1881-11-22 Joseph
US271A (en) * 1837-07-17 George wilbur
US1252616A (en) * 1917-03-02 1918-01-08 Ellen W Reif Toy.
US1789885A (en) * 1929-03-09 1931-01-20 Skinner Thomas Coal chute
US2218444A (en) * 1938-04-11 1940-10-15 George S Vineyard Merchandise dispenser
US2742288A (en) * 1953-06-04 1956-04-17 Jacques A Brunel Chute for sking and tobogganing
US3064784A (en) * 1960-08-01 1962-11-20 Admos Inc Supporting structures for chutes
US4418813A (en) * 1981-05-20 1983-12-06 Modular Automation, Inc. Modular open chuting
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
US6196370B1 (en) * 1998-03-27 2001-03-06 Tonoga Limited Package conveying surface with liner
JP3821587B2 (ja) * 1998-08-31 2006-09-13 ユニ・チャーム株式会社 ウェットティッシュの積層体及びこれが収納された製品
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
US20030027751A1 (en) * 2001-04-10 2003-02-06 Genvec, Inc. VEGF fusion proteins
WO2003037172A2 (en) * 2001-11-01 2003-05-08 Gpc Biotech Inc. Endothelial-cell binding peptides for diagnosis and therapy
US20030221931A1 (en) 2002-02-28 2003-12-04 Steve Marsh Sliding device

Also Published As

Publication number Publication date
US20030221931A1 (en) 2003-12-04
US20130130996A1 (en) 2013-05-23
US20040171552A1 (en) 2004-09-02
US8383769B2 (en) 2013-02-26
EP1519945A2 (de) 2005-04-06
US20120028913A1 (en) 2012-02-02
AU2003209636A1 (en) 2003-09-09
ATE465171T1 (de) 2010-05-15
AU2003209636A8 (en) 2003-09-09
WO2003072599A3 (en) 2003-12-18
EP2287175A3 (de) 2012-05-16
US8039440B2 (en) 2011-10-18
WO2003072599A2 (en) 2003-09-04
US20100173848A1 (en) 2010-07-08
US7488717B2 (en) 2009-02-10
EP2287175A2 (de) 2011-02-23
EP1519945B1 (de) 2010-04-21
US8796227B2 (en) 2014-08-05

Similar Documents

Publication Publication Date Title
ATE465171T1 (de) Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren
EP2540309A3 (de) Gewebeschützende Peptide und ihre Verwendung
HK1156862A1 (en) Compstatin analogs with improved activity
BRPI0514115A (pt) terapia de combinação empregando-se proteìnas de fusão de transferrina compreendendo glp-1
WO2005035551A3 (en) Inhibitors of proteins that bind phosphorylated molecules
ATE530560T1 (de) Vegf bindende und geträgerte peptide zur behandlung von hautkrankheiten
RU2007142191A (ru) Варианты бета-цепи hgf
WO2004066958A3 (en) Caspase-9:bir3 domain of xiap complexes and methods of use
DE502005007926D1 (de) Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
TW200700089A (en) Recombinant protein comprising starch binding domain and use thereof
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
ATE451387T1 (de) Neue mit dem zelltod assoziierte proteine aus der thap familie und par4 verwandte signalwege, die bei der kontrolle von apoptosis involviert sind
ATE362487T1 (de) N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
ATE536366T1 (de) Peptidinhibitoren von hk2 und deren anwendung
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
DE69738600D1 (de) Neuroaktive peptide
ATE345383T1 (de) Säugeradhäsionprotease
AU2003302901A8 (en) Human recombinant endooligopeptidase a (heopa)
DE69535380D1 (de) Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen
WO2007073845A8 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2003085377A3 (en) Novel pancortin-pablo protein interactions and methods of use thereof
WO2002012283A3 (en) Disintegrin homologs, zsnk10, zsnk11, and zsnk12
WO2002010198A3 (en) Polynucleotides and polypeptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition